本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ascendis Pharma A/S

174.89
-0.0750-0.04%
盤前175.630.7415+0.42%08:00 EDT
成交量:32.05萬
成交額:5,642.47萬
市值:105.90億
市盈率:-27.79
高:179.50
開:175.50
低:173.81
收:174.96
資料載入中...
2019/10/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/14

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/05/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]